Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis-Reference-Cited by-同舟云学术

Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis

Published:2018-06-11 Issue:2 Volume:8 Page:121-129
ISSN:2235-1795
Container-title:Liver Cancer
language:en
Short-container-title:Liver Cancer

Author:

Hiraoka Atsushi^ORCID,Kumada Takashi,Tsuji Kunihiko,Takaguchi Koichi,Itobayashi Ei,Kariyama Kazuya,Ochi Hironori,Tajiri Kazuto^ORCID,Hirooka Masashi,Shimada Noritomo,Ishikawa Toru,Tachi Yoshihiko,Tada Toshifumi,Toyoda Hidenori,Nouso Kazuhiro,Joko Kouji,Hiasa Yoichi,Michitaka Kojiro,Kudo Masatoshi,

Publisher

S. Karger AG

Subject

Oncology,Hepatology

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic arterial infusion of autologous CD34+ cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trial;Regenerative Therapy;2024-12

2. The Modified Albumin–Bilirubin (ALBI) Grade Reflect the Fate of Limb Prognosis in Patients with Chronic Limb-Threatening Ischemia;Annals of Vascular Surgery;2024-11

3. Single-molecule sequencing of the whole HCV genome revealed envelope deletions in decompensated cirrhosis associated with NS2 and NS5A mutations;Journal of Gastroenterology;2024-09-03

4. Efficacy of lenvatinib and transarterial chemoembolization combination therapy in patients with hepatocellular carcinoma administered an insufficient dose of early lenvatinib;Molecular and Clinical Oncology;2024-07-10

5. Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child–Pugh A category: A multicenter study;Hepatology Research;2024-07-02